U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
190471190471S0121, Neoadjuvant Carboplatin, Paclitaxel, and Gemcitabine Followed by Cisplatin and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Carcinoma of the UrotheliumCompletedNo Results AvailableBladder Cancer|Urethral CancerDrug: carboplatin|Drug: cisplatin|Drug: gemcitabine hydrochloride|Drug: paclitaxel|Procedure: neoadjuvant therapy|Radiation: radiation therapyhttps://ClinicalTrials.gov/show/NCT00055835
190472190472Combination Chemotherapy and Oblimersen in Treating Patients With Advanced Colorectal CancerCompletedNo Results AvailableColorectal CancerBiological: oblimersen sodium|Drug: fluorouracil|Drug: leucovorin calcium|Drug: oxaliplatinhttps://ClinicalTrials.gov/show/NCT00055822
190473190473Bevacizumab and PEG-Interferon Alfa-2b in Treating Patients With Metastatic or Unresectable Carcinoid TumorsCompletedNo Results AvailableMetastatic Gastrointestinal Carcinoid Tumor|Recurrent Gastrointestinal Carcinoid Tumor|Regional Gastrointestinal Carcinoid TumorBiological: PEG-interferon alfa-2b|Biological: bevacizumab|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00055809
190474190474Monoclonal Antibody Therapy in Treating Patients With Recurrent Hodgkin's LymphomaCompletedNo Results AvailableLymphomaBiological: apolizumabhttps://ClinicalTrials.gov/show/NCT00055783
190475190475Erlotinib Plus Docetaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Head and Neck CancerCompletedNo Results AvailableRecurrent Salivary Gland Cancer|Recurrent Squamous Cell Carcinoma of the Hypopharynx|Recurrent Squamous Cell Carcinoma of the Larynx|Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity|Recurrent Squamous Cell Carcinoma of the Nasopharynx|RecurrenDrug: erlotinib hydrochloride|Drug: docetaxel|Other: laboratory biomarker analysis|Other: pharmacological studyhttps://ClinicalTrials.gov/show/NCT00055770
190476190476Tipifarnib, Gemcitabine, and Cisplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerCompletedNo Results AvailableStage IIIB Non-small Cell Lung Cancer|Stage IV Non-small Cell Lung CancerDrug: tipifarnib|Drug: cisplatin|Drug: gemcitabine hydrochloride|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00055757
190477190477Hormone Therapy With or Without Docetaxel And Estramustine in Treating Patients With Prostate Cancer That is Locally Advanced or At High Risk of RelapseActive, not recruitingNo Results AvailableProstate CancerDrug: bicalutamide|Drug: buserelin|Drug: cyproterone acetate|Drug: docetaxel|Drug: estramustine phosphate sodium|Drug: flutamide|Drug: goserelin acetate|Drug: leuprolide acetate|Drug: nilutamide|Drug: triptorelin|Procedure: conventional surgery|Procedure: neoadjuvant therapy|Radiation: radiation therapyhttps://ClinicalTrials.gov/show/NCT00055731
190478190478Silymarin (Milk Thistle Extract) in Treating Patients With Acute Lymphoblastic Leukemia Who Are Receiving ChemotherapyCompletedNo Results AvailableDrug/Agent Toxicity by Tissue/Organ|LeukemiaDietary Supplement: silymarinhttps://ClinicalTrials.gov/show/NCT00055718
190479190479PV701 in Treating Patients With Advanced or Recurrent Peritoneal CancerCompletedNo Results AvailableCancerBiological: PV701https://ClinicalTrials.gov/show/NCT00055705
190480190480Bevacizumab in Treating Patients With Unresectable Nonmetastatic Liver CancerCompletedNo Results AvailableAdult Primary Hepatocellular Carcinoma|Localized Unresectable Adult Primary Liver Cancer|Recurrent Adult Primary Liver CancerBiological: bevacizumab|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00055692
190481190481Combination Chemotherapy in Treating Women With Stage I Breast CancerCompletedNo Results AvailableBreast CancerDrug: cyclophosphamide|Drug: epirubicin hydrochloride|Drug: fluorouracilhttps://ClinicalTrials.gov/show/NCT00055679
190482190482Compassionate Use of Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Gastrointestinal TractCompletedNo Results AvailableGraft Versus Host DiseaseDrug: beclomethasone dipropionatehttps://ClinicalTrials.gov/show/NCT00055666
190483190483Donor Umbilical Cord Blood Transplantation in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic DisordersCompletedNo Results AvailableLeukemia|Lymphoma|Myelodysplastic Syndromes|Myelodysplastic-Myeloproliferative DiseasesBiological: anti-thymocyte globulin|Biological: filgrastim|Drug: busulfan|Drug: cyclophosphamide|Drug: cyclosporine|Drug: fludarabine phosphate|Drug: melphalan|Drug: methylprednisolone|Procedure: umbilical cord blood transplantation|Radiation: radiation therapyhttps://ClinicalTrials.gov/show/NCT00055653
190484190484Molecular Risk Assessment in Planning Treatment for Patients With Non-Hodgkin's LymphomaCompletedNo Results AvailableLymphomaBiological: rituximab|Drug: cyclophosphamide|Drug: doxorubicin hydrochloride|Drug: prednisone|Drug: vincristine sulfate|Genetic: microarray analysishttps://ClinicalTrials.gov/show/NCT00055640
190485190485Topotecan in Treating Patients With Advanced Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal CancerCompletedNo Results AvailableFallopian Tube Cancer|Ovarian Cancer|Primary Peritoneal Cavity CancerDrug: topotecan hydrochloride|Procedure: adjuvant therapyhttps://ClinicalTrials.gov/show/NCT00055614
190486190486Combination Chemotherapy and Radiation Therapy With or Without Surgery In Treating Patients With Stage II or Stage III Bladder CancerActive, not recruitingNo Results AvailableBladder CancerDrug: cisplatin|Drug: fluorouracil|Drug: paclitaxel|Radiation: radiation therapyhttps://ClinicalTrials.gov/show/NCT00055601
190487190487Nervous System Function in Normal Volunteers During Cycling TrainingCompletedNo Results AvailableHealthyProcedure: Locomotor traininghttps://ClinicalTrials.gov/show/NCT00055588
190488190488Cholinergic Modulation of Condition and Emotion in Mood Disorders: Functional Neuroimaging StudiesTerminatedNo Results AvailableMood Disorders|Healthy|Unipolar Depression|Bipolar DepressionDrug: Transderm Scopolaminehttps://ClinicalTrials.gov/show/NCT00055575
190489190489Study to Compare the Efficacy and Safety of Two CC-5013 Dose Regimens in Subjects With Metastatic Malignant MelanomaCompletedNo Results AvailableMelanoma|Neoplasm MetastasisDrug: CC 5013https://ClinicalTrials.gov/show/NCT00055562
190490190490Dextromethorphan to Treat Patients With Voice SpasmsCompletedNo Results AvailableVoice DisordersDrug: Dextromethorphan|Drug: Lorazepamhttps://ClinicalTrials.gov/show/NCT00055549
190491190491Safety and Efficacy of Natalizumab in Combination With Remicade in the Treatment of Crohn's DiseaseCompletedNo Results AvailableCrohn's DiseaseDrug: Natalizumabhttps://ClinicalTrials.gov/show/NCT00055536
190492190492A Study of the Human Anti-TNF Antibody Adalimumab for the Induction of Clinical Remission in Subjects With Crohn's DiseaseCompletedNo Results AvailableCrohn's DiseaseDrug: Adalimumab (D2E7)https://ClinicalTrials.gov/show/NCT00055523
190493190493A Blinded Study Conducted at Multiple Centers Evaluating Various Doses of an Investigational Agent (BO-653) Against Placebo, for Safety and Effectiveness in Preventing Post-Angioplasty Blood Vessel Re-Closure (Restenosis) in Stented Vessels.CompletedNo Results AvailableGraft Occlusion, Vascular|Coronary Restenosis|AtherosclerosisDrug: BO-653https://ClinicalTrials.gov/show/NCT00055510
190494190494Remission in Subjects With Crohn's Disease, 1 Year PhaseCompletedHas ResultsCrohn's DiseaseBiological: Double-blind (DB) adalimumab placebo|Biological: DB adalimumab 40 mg eow|Biological: DB adalimumab 40 mg ew|Biological: OL adalimumab 40 mghttps://ClinicalTrials.gov/show/NCT00055497
190495190495A Study to Measure the Safety and Effectiveness of Zonisamide in Subjects With Migraine HeadacheCompletedNo Results AvailableMigraine HeadacheDrug: zonisamidehttps://ClinicalTrials.gov/show/NCT00055484
190496190496A Phase IIa. Open-label, Multicenter, Dose-escalation Study to Assess the Tolerability and Pharmacokinetics of ZD4054 (Zibotentan) Given Orally Once Daily in Subjects With Metastatic Prostate CancerCompletedHas ResultsProstatic Neoplasms|Metastases, NeoplasmDrug: ZD4054 10 mg|Drug: ZD4054 15 mg|Drug: ZD4054 22.5 mghttps://ClinicalTrials.gov/show/NCT00055471
190497190497IdB 1016 Treatment for Hepatitis C DiseaseCompletedNo Results AvailableHepatitis C, ChronicDrug: IdB 1016https://ClinicalTrials.gov/show/NCT00055445
190498190498Gemzar (Gemcitabine) and Alimta (Pemetrexed) in the Treatment of Patients With Recurrent Platinum-Sensitive and Platinum-Resistant Ovarian or Peritoneal CancerTerminatedNo Results AvailableOvarian Cancer|Peritoneal CancerDrug: Gemzar and Alimtahttps://ClinicalTrials.gov/show/NCT00055432
190499190499A Study of Cetuximab in Patients Who Have Stage IV Colorectal CancerCompletedNo Results AvailableColorectal NeoplasmsBiological: Cetuximabhttps://ClinicalTrials.gov/show/NCT00055419
190500190500Drug Treatment for Pathological GamblingCompletedNo Results AvailableGamblingDrug: Bupropionhttps://ClinicalTrials.gov/show/NCT00055393

* Görseller ve İçerik tekif hakkına sahip olabilir